Ethical problems of evaluating a new treatment for melioidosis

Allen C. Cheng; Michael Lowe; Dianne P Stephens; Bart J Currie

Ethical problems of evaluating a new treatment for melioidosis

Allen C. Cheng
, Michael Lowe
, Dianne P Stephens
, Bart J Currie

Research output: Contribution to journal › Review Article › Research › peer-review

Abstract

When mortality from melioidosis fell sharply after multiple changes in management at an Australian hospital, doctors wanted to identify whether a new drug was responsible. But designing a trial that was ethically acceptable proved impossible.

Original language	English
Pages (from-to)	1280-1282
Number of pages	3
Journal	BMJ
Volume	327
Issue number	7426
Publication status	Published - 29 Nov 2003
Externally published	Yes

Cite this

@article{c6863938558342e89e81c7e4e32677ed,

title = "Ethical problems of evaluating a new treatment for melioidosis",

abstract = "When mortality from melioidosis fell sharply after multiple changes in management at an Australian hospital, doctors wanted to identify whether a new drug was responsible. But designing a trial that was ethically acceptable proved impossible.",

author = "Cheng, \{Allen C.\} and Michael Lowe and Stephens, \{Dianne P\} and Currie, \{Bart J\}",

year = "2003",

month = nov,

day = "29",

language = "English",

volume = "327",

pages = "1280--1282",

journal = "BMJ",

issn = "0959-8146",

publisher = "BMJ",

number = "7426",

}

TY - JOUR

T1 - Ethical problems of evaluating a new treatment for melioidosis

AU - Cheng, Allen C.

AU - Lowe, Michael

AU - Stephens, Dianne P

AU - Currie, Bart J

PY - 2003/11/29

Y1 - 2003/11/29

N2 - When mortality from melioidosis fell sharply after multiple changes in management at an Australian hospital, doctors wanted to identify whether a new drug was responsible. But designing a trial that was ethically acceptable proved impossible.

AB - When mortality from melioidosis fell sharply after multiple changes in management at an Australian hospital, doctors wanted to identify whether a new drug was responsible. But designing a trial that was ethically acceptable proved impossible.

UR - https://www.scopus.com/pages/publications/0345687931

M3 - Review Article

C2 - 14644975

AN - SCOPUS:0345687931

SN - 0959-8146

VL - 327

SP - 1280

EP - 1282

JO - BMJ

JF - BMJ

IS - 7426

ER -

Ethical problems of evaluating a new treatment for melioidosis

Abstract

Other files and links

Cite this